IP Library Assignment 025931/0472
Patent Assignment
Reel/Frame 025931/0472

Assignment of Assignor's Interest

Recorded: 2011-03-10 Pages: 6
Assignor
Assignee
HOLOGIC, INC.
35 CROSBY DRIVE, BEDFORD, MASSACHUSETTS, 01730
Covered Properties (24)
Proteomic Analysis of Biological Fluids
Methods and Systems for Identification of Macromolecules
Diagnosis of Fetal Aneuploidy
Proteomic Analysis of Biological Fluids
Gestational Age Dependent Proteomic Changes of Human Maternal Serum for Monitoring Maternal and Fetal Health
Maternal Serum Biomarkers for Detection of Pre-Eclampsia
Detection of Intraamniotic Infection
Biomarkers for Detection of Neonatal Sepsis in Biological Fluid
Proteomic Analysis of Biological Fluids
Patent: 7,191,068 →
Application: 10/400,005 →
Publication: US 2004/0197930
Methods and systems for identification of macromolecules
Application: 10/789,424 →
Publication: US 2005/0192755
Diagnosis of fetal aneuploidy
Application: 11/232,335 →
Publication: US 2006/0094039
Proteomic analysis of biological fluids
Application: 11/473,797 →
Publication: US 2009/0055099
Diagnosis of Intra-Uterine Infection by Proteomic Analysis of Cervical-Vaginal Fluids
Patent: 8,068,990 →
Application: 11/595,221 →
Publication: US 2007/0161125
Proteomic analysis of biological fluids
Application: 12/217,687 →
Publication: US 2008/0299594
Gestational Age Dependent Proteomic Changes of Human Maternal Serum for Monitoring Maternal and Fetal Health
Application: 12/363,651 →
Publication: US 2010/0017143
Maternal Serum Biomarkers for Detection of Pre-Eclampsia
Application: 12/363,659 →
Publication: US 2010/0016173
Biomarkers for Detection of Neonatal Sepsis in Biological Fluid
Application: 12/693,387 →
Publication: US 2010/0190652
Detection of Intraamniotic Infection
Patent: 8,663,576 →
Application: 12/952,017 →
Publication: US 2011/0184254
Diagnosis of fetal down's syndrome
Application: 60/611,654 →
Maternal Serum Biomarkers for Detection of Pre-Eclampsia
Application: 61/024,859 →
Gestational Age Dependent Proteomic Changes of Human Maternal Serum for Monitoring Maternal and Fetal Health
Application: 61/024,865 →
Biomarkers for Detection of Neonatal Sepsis in Biological Fluid
Application: 61/147,635 →
Multivariate Immunodiagnostic Biomarkers in Cervical Vaginal Fluid for Detection of Intraamniotic Infection
Application: 61/264,633 →
Protein Biomarker Test of Intraamniotic Infection
Application: 61/362,192 →
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 6, 2010
From: NAGALLA, SRINIVASA; GRAVETT, MICHAEL
To: PROTEOGENIX, INC.
Reel/Frame 023744/0489 →
Security Agreement Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
Security Interest Release Reel/Frame 028810/0745 Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
Reel/Frame 035820/0239 →
Security Agreement Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 028810 Frame: 0745. Assignor(S) Hereby Confirms the Security Agreement. Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
Corrective Assignment to Correct the Incorrect Patent No. 8081301 Previously Recorded at Reel: 035820 Frame: 0239. Assignor(S) Hereby Confirms the Security Interest Release. Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP
Reel/Frame 044727/0529 →
Security Interest Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →